Nov 21, 2023 · Xtandi is an androgen receptor inhibitor used to treat certain prostate cancers. Xtandi works by preventing the actions of androgens (male hormones), to help control cancer growth and decrease tumor size. Xtandi is used when prostate cancer no longer responds to hormone therapy or surgical treatment.

Apr 3, 2023 · Xtandi should not be given at the same time as strong CYP2C8 inducers, such as rifampicin, secobarbital, phenobarbital, or phenytoin. If coadministration is unavoidable, increase the dose of Xtandi to 240mg once daily. Return the Xtandi dose to 160mg/day or the dose previously prescribed when the strong CYP2C8 inhibitor is discontinued.

May 3, 2024 · Some dosage forms listed on this page may not apply specifically to the brand name Xtandi. Applies to enzalutamide: oral capsule liquid filled, oral tablet. Serious side effects of Xtandi. Along with its needed effects, enzalutamide (the active ingredient contained in Xtandi) may cause some unwanted effects.

Xtandi Coupons, Copay Cards and Rebates. Xtandi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Jan 22, 2025 · For patients who receive XTANDI with or without a GnRH analog, treatment can be suspended if PSA is undetectable (< 0.2 ng/mL) after 36 weeks of therapy. Reinitiate treatment when PSA has increased to ≥ 2.0 ng/mL for patients who had prior radical prostatectomy or ≥ 5.0 ng/mL for patients who had prior primary radiation therapy.

Nov 22, 2023 · Xtandi comes in the form of a capsule or a tablet, which is taken once a day alongside a gonadotropin-releasing hormone (GnRH) analog or bilateral orchiectomy. Xtandi is typically taken until prostate cancer starts to progress or spread (metastasize), or until the patient can no longer tolerate therapy because of the side effects or adverse ...

Nov 21, 2023 · Xtandi (enzalutamide) is an androgen receptor inhibitor or anti-androgen. Androgens are a group of hormones, which includes testosterone, that stimulate prostate cancer cells to grow. Xtandi works by blocking the action of androgens at the androgen receptor - reducing how often androgens can connect with the receptor - which helps prevent ...

Sep 11, 2024 · Xtandi is typically taken until prostate cancer starts to progress or spread (metastasize), or until the patient can no longer tolerate therapy because of the side effects or adverse events it causes. In clinical trials, Xtandi was effective at delaying the time to disease progression in men with advanced prostate cancer.

Dec 2, 2024 · Xtandi is typically taken until prostate cancer starts to progress or spread (metastasize), or until the patient can no longer tolerate therapy because of the side effects or adverse events it causes. In clinical trials, Xtandi was effective at delaying the time to disease progression in men with advanced prostate cancer.

Sep 16, 2013 · XTANDI is a strong CYP3A4 inducer and a moderate CYP2C9 and CYP2C19 inducer. The coadministration of XTANDI decreases the concentrations of certain CYP3A4, CYP2C9, or CYP2C19 substrates [see Clinical Pharmacology ], which may reduce the efficacy of these substrates. Avoid the coadministration of XTANDI with certain CYP3A4, CYP2C9, or …